Russell Investments Group, Ltd. Cyclerion Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$2.18 - $4.29 $270,483 - $532,281	-124,075 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$2.69 - $5.12 $267,038 - $508,267	99,271 Added 400.22%	124,075 $345,000
Q4 2020 Feb 08, 2021	SELL	$2.25 - $7.12 $60,189 - $190,467	-26,751 Reduced 51.89%	24,804 $75,000
Q3 2020 Nov 09, 2020	BUY	$3.46 - $8.39 $82,309 - $199,589	23,789 Added 85.68%	51,555 $312,000
Q2 2020 Aug 05, 2020	BUY	$2.37 - $7.14 $8,430 - $25,396	3,557 Added 14.69%	27,766 $163,000
Q4 2019 Jan 29, 2020	SELL	$1.8 - $13.43 $121,113 - $903,637	-67,285 Reduced 73.54%	24,209 $64,000
Q3 2019 Nov 01, 2019	BUY	$8.12 - $14.54 $742,931 - $1.33 Million	91,494 New	91,494 $1.11 Million

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $139M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.